-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-228-tables-1-2.pdf
June 02, 2025 - • Leukocyte count elevated or depressed for age (not secondary to
chemotherapy- induced leukopenia
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-229-section-1-tables-1-2.pdf
June 02, 2025 - • Leukocyte count elevated or depressed for age (not secondary to
chemotherapy-induced leukopenia
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0231-section-1-tables-1-2.pdf
June 02, 2025 - • Leukocyte count elevated or depressed for age (not secondary to chemotherapy-induced
leukopenia
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol4/Advances-Miller_93.pdf
March 12, 2008 - The secondary objective was to determine
the barcode scan rates of medications removed by the override … Numerous medication errors secondary to ADM override have been identified in the literature. … The secondary objective was to determine the
3
barcode scan rates of medications and patient
-
www.ahrq.gov/ncepcr/tools/confid-report/foreword.html
February 01, 2016 - A secondary aim is to foster discussion among report developers, the broader quality improvement and
-
www.ahrq.gov/hai/universal-icu-decolonization/universal-icu-refs.html
September 01, 2013 - Efficacy and safety of 2% mupirocin ointment in the treatment of primary and secondary skin infections–an … Topical 2% mupirocin versus 2% fusidic acid ointment in the treatment of primary and secondary skin infections
-
www.ahrq.gov/sites/default/files/2025-04/newman-toker2-report.pdf
January 01, 2025 - Symptom data included chief and secondary
complaints, plus symptom attributes for the chief complaint … Symptom data included chief and secondary complaints plus symptom
attributes for the chief complaint … Measures/Analysis
Symptom data included chief and secondary complaints plus symptom attributes for … Secondary analyses were conducted to test for significant
demographic (age, sex, race, education) or … Secondary Analyses and Data Handling
Secondary analyses were conducted to test for significant heterogeneity
-
www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/resources/diagnostic-toolkit/14-diagnostic-safety-toolkit-references.pdf
November 24, 2020 - Eliciting the patient’s agenda - secondary analysis of
recorded clinical encounters. … Eliciting the patient’s agenda- secondary analysis of recorded
clinical encounters.
-
www.ahrq.gov/funding/training-grants/k-awards.html
September 01, 2023 - Also, candidates can identify a secondary mentor who possesses a skill set that is particularly relevant
-
www.ahrq.gov/es/hai/universal-icu-decolonization/universal-icu-refs.html
September 01, 2013 - Efficacy and safety of 2% mupirocin ointment in the treatment of primary and secondary skin infections–an … Topical 2% mupirocin versus 2% fusidic acid ointment in the treatment of primary and secondary skin infections
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/education/curriculum-tools/clabsitools/clabsitoolsap3.ppt
January 01, 2003 - Infection elsewhere (remote, i.e., urinary tract infection or wound) — secondary source
Colonization … patient with proven CLABSI
(i.e., blood culture positive for a recognized pathogen with no identified secondary
-
www.ahrq.gov/ncepcr/tools/transform-qi/facilitation/dashboard.html
February 01, 2025 - Practices Aspirin Use Care: Tasks for the Practice Facilitator, p. 12 Checklist to increase aspirin use for secondary
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-194-section-1-tables-6-10.pdf
June 02, 2025 - brain 191.x
Malignant neoplasm of pituitary gland 194.3
Malignant neoplasm of pineal gland 194.4
Secondary
-
www.ahrq.gov/hai/cauti-tools/phys-championsgd/section2.html
October 01, 2015 - Phlebitis (inflammation of the vein) can also occur, either related to chemical irritation of the vein or secondary
-
www.ahrq.gov/patient-safety/resources/simulation-issue-brief3.html
July 01, 2024 - Optimize the direct and secondary benefits, such as designing and implementing simulations that address
-
www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/recruitment-brochure-nc.pdf
January 01, 2003 - “Blood Pressure Reduction and Secondary Prevention of Stroke and Other Vascular Events: A Systematic
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0230-section-1-tables-1-3.pdf
June 02, 2025 - • Leukocyte count elevated or depressed for age (not secondary to chemotherapy-
induced leukopenia
-
www.ahrq.gov/sites/default/files/2025-04/rising-report.pdf
January 01, 2025 - A secondary learning outcome was an assessment of predictors of achieving mastery at
the first attempt … Secondary analysis: For secondary outcomes, group differences in categorical variables were evaluated … Outcomes:
Secondary Analysis:
Kirkpatrick Level 1 – Reaction: Post-course survey responses were overall … Outcomes:
Secondary Analysis
Additional Exploratory Analyses
5. C. Discussion
5. D.
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/cauti-tools/impl-guide/implementation-guide-appendix-a.docx
January 01, 2008 - withhold relevant information
· Addresses others’ concerns in a manner that is forthright and informed
Secondary … or to try to influence others, but does so in a way that respects the personal boundaries of others
Secondary
-
www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/mrsa/047-evidence-behind-decolonization-strategies-notes.docx
October 01, 2024 - outcome was combined MRSA or VRE clinical cultures attributable to a non-ICU unit, as well as a key secondary … significant difference was observed between the Routine Care and Decolonization arms in the primary or secondary … This was true for both the primary outcome of MRSA and VRE clinical cultures and the secondary outcome … Secondary outcomes included MRSA clinical cultures, all-cause bloodstream infections, and emergence of … Slide 39
Swap Out Trial Results: MRSA Cultures
SAY:
For the secondary outcome of MRSA clinical cultures